SCHEMBL8285368

SCHEMBL8285368

NC(=O)C1(Nc2ccccc2)CCN([C@H]2CCCC[C@@H]2O)CC1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 8/20 0.51
CYP2D6 P10635 2/20 0.47
SIGMAR1 Q99720 2/20 0.47
TSHR P16473 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALDH1A1 P00352 1/20 0.46
APEX1 P27695 1/20 0.46
BLM P54132 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA14 Q9ULX7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287288 0.88 SLC18A3 (0.55) SLC18A3SIGMAR1
SCHEMBL8285369 0.88 SLC18A3 (0.44) SLC18A3SIGMAR1
SCHEMBL8288007 0.88 SLC18A3 (0.49) SLC18A3SIGMAR1
SCHEMBL5557067 0.85 SLC6A9 (0.48) CA12CA1CA2CA4CA5A
SCHEMBL5557070 0.85 SLC6A9 (0.48) CA12CA1CA2CA4CA5A
SCHEMBL14573345 0.85 SLC6A9 (0.48) CA12CA1CA2CA4CA5A
SCHEMBL8287620 0.85 CA12 (0.42) SLC18A3CYP2D6ALDH1A1CA12CA1
SCHEMBL27539703 0.84 CA12 (0.43) SLC18A3CYP2D6SIGMAR1TSHRSMN1; SMN2
SCHEMBL27455915 0.84 CA12 (0.43) SLC18A3CYP2D6SIGMAR1TSHRSMN1; SMN2
SCHEMBL8285372 0.80 SLC18A3 (0.50) SLC18A3CYP2D6TSHRSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678177-B1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS HOFFMANN LA ROCHE (CH) 2007-11-28 EP disclosed
WO-2005040166-A1 TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2005-05-06 WO disclosed